152 related articles for article (PubMed ID: 10874309)
1. Rapid and comprehensive determination of cytochrome P450 CYP2D6 poor metabolizer genotypes by multiplex polymerase chain reaction.
Roberts R; Joyce P; Kennedy MA
Hum Mutat; 2000; 16(1):77-85. PubMed ID: 10874309
[TBL] [Abstract][Full Text] [Related]
2. Rapid detection of CYP2D6 null alleles by long distance- and multiplex-polymerase chain reaction.
Stüven T; Griese EU; Kroemer HK; Eichelbaum M; Zanger UM
Pharmacogenetics; 1996 Oct; 6(5):417-21. PubMed ID: 8946473
[TBL] [Abstract][Full Text] [Related]
3. Detection of the poor metabolizer-associated CYP2D6(D) gene deletion allele by long-PCR technology.
Steen VM; Andreassen OA; Daly AK; Tefre T; Børresen AL; Idle JR; Gulbrandsen AK
Pharmacogenetics; 1995 Aug; 5(4):215-23. PubMed ID: 8528268
[TBL] [Abstract][Full Text] [Related]
4. Rapid detection of common cytochrome P450 2D6 alleles in Caucasians.
Roberts RL; Kennedy MA
Clin Chim Acta; 2006 Apr; 366(1-2):348-51. PubMed ID: 16364273
[TBL] [Abstract][Full Text] [Related]
5. Cytochrome P450 2D6 variants in a Caucasian population: allele frequencies and phenotypic consequences.
Sachse C; Brockmöller J; Bauer S; Roots I
Am J Hum Genet; 1997 Feb; 60(2):284-95. PubMed ID: 9012401
[TBL] [Abstract][Full Text] [Related]
6. Low frequency of defective alleles of cytochrome P450 enzymes 2C19 and 2D6 in the Turkish population.
Aynacioglu AS; Sachse C; Bozkurt A; Kortunay S; Nacak M; Schröder T; Kayaalp SO; Roots I; Brockmöller J
Clin Pharmacol Ther; 1999 Aug; 66(2):185-92. PubMed ID: 10460072
[TBL] [Abstract][Full Text] [Related]
7. Assessment of the predictive power of genotypes for the in-vivo catalytic function of CYP2D6 in a German population.
Griese EU; Zanger UM; Brudermanns U; Gaedigk A; Mikus G; Mörike K; Stüven T; Eichelbaum M
Pharmacogenetics; 1998 Feb; 8(1):15-26. PubMed ID: 9511177
[TBL] [Abstract][Full Text] [Related]
8. [Allele specific amplification for CYP2D6 gene related to intermediate metabolizer in Chinese subjects].
Chen B; Cai WM; Ling SS
Yao Xue Xue Bao; 2001 Feb; 36(2):88-91. PubMed ID: 12579870
[TBL] [Abstract][Full Text] [Related]
9. Cytochrome P450 polymorphism--molecular, metabolic, and pharmacogenetic aspects. IV. Application of long polymerase chain reaction for identification of CYP2D6 gene duplication.
Pułczyńska A; Łukaszkiewicz J; Wojnar M; Tomaszewski P; Kubiak-Tomaszewska G; Pachecka J
Acta Pol Pharm; 2011; 68(1):9-13. PubMed ID: 21485696
[TBL] [Abstract][Full Text] [Related]
10. Genetic analysis of the CYP2D6 locus in a Hong Kong Chinese population.
Garcia-Barceló M; Chow LY; Chiu HF; Wing YK; Lee DT; Lam KL; Waye MM
Clin Chem; 2000 Jan; 46(1):18-23. PubMed ID: 10620567
[TBL] [Abstract][Full Text] [Related]
11. CYP2D6 phenotype-genotype relationships in African-Americans and Caucasians in Los Angeles.
Leathart JB; London SJ; Steward A; Adams JD; Idle JR; Daly AK
Pharmacogenetics; 1998 Dec; 8(6):529-41. PubMed ID: 9918137
[TBL] [Abstract][Full Text] [Related]
12. Phenotype and genotype analysis of debrisoquine hydroxylase (CYP2D6) in a black Zimbabwean population. Reduced enzyme activity and evaluation of metabolic correlation of CYP2D6 probe drugs.
Masimirembwa C; Hasler J; Bertilssons L; Johansson I; Ekberg O; Ingelman-Sundberg M
Eur J Clin Pharmacol; 1996; 51(2):117-22. PubMed ID: 8911874
[TBL] [Abstract][Full Text] [Related]
13. Detection of CYP2D6*3 and 2D6*4 allelic variants by PCR-restriction fragment length polymorphism.
Topić E; Stefanović M; Nikolić V; Zoricić I; Ivanisević AM; Zuntar I
Clin Chem Lab Med; 1998 Aug; 36(8):655-8. PubMed ID: 9806480
[TBL] [Abstract][Full Text] [Related]
14. A new simple diagnostic assay for the identification of the major CYP2D6 genotypes by DNA sequencing analysis.
James HM; Coller JK; Gillis D; Bahnisch J; Sallustio BC; Somogyi AA
Int J Clin Pharmacol Ther; 2004 Dec; 42(12):719-23. PubMed ID: 15624288
[TBL] [Abstract][Full Text] [Related]
15. Frequencies of CYP2D6 mutant alleles in a normal Japanese population and metabolic activity of dextromethorphan O-demethylation in different CYP2D6 genotypes.
Kubota T; Yamaura Y; Ohkawa N; Hara H; Chiba K
Br J Clin Pharmacol; 2000 Jul; 50(1):31-4. PubMed ID: 10886115
[TBL] [Abstract][Full Text] [Related]
16. A rapid multiplex PCR assay that can reliably discriminate the cytochrome P450 2D6 whole-gene deletion allele from 2D6*10 alleles.
Okubo M; Murayama N; Miura J; Shimizu M; Yamazaki H
Clin Chim Acta; 2012 Oct; 413(19-20):1675-7. PubMed ID: 22634574
[TBL] [Abstract][Full Text] [Related]
17. Identification of CYP2D6 alleles by single nucleotide polymorphism analysis using pyrosequencing.
Zackrisson AL; Lindblom B
Eur J Clin Pharmacol; 2003 Oct; 59(7):521-6. PubMed ID: 13680033
[TBL] [Abstract][Full Text] [Related]
18. Rapid detection of the CYP2D6*3, CYP2D6*4, and CYP2D6*6 alleles by tetra-primer PCR and of the CYP2D6*5 allele by multiplex long PCR.
Hersberger M; Marti-Jaun J; Rentsch K; Hänseler E
Clin Chem; 2000 Aug; 46(8 Pt 1):1072-7. PubMed ID: 10926885
[TBL] [Abstract][Full Text] [Related]
19. CYP2D7-2D6 hybrid tandems: identification of novel CYP2D6 duplication arrangements and implications for phenotype prediction.
Gaedigk A; Fuhr U; Johnson C; Bérard LA; Bradford D; Leeder JS
Pharmacogenomics; 2010 Jan; 11(1):43-53. PubMed ID: 20017671
[TBL] [Abstract][Full Text] [Related]
20. Optimization of cytochrome P4502D6 (CYP2D6) phenotype assignment using a genotyping algorithm based on allele frequency data.
Gaedigk A; Gotschall RR; Forbes NS; Simon SD; Kearns GL; Leeder JS
Pharmacogenetics; 1999 Dec; 9(6):669-82. PubMed ID: 10634130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
